246 related articles for article (PubMed ID: 12639159)
1. Ipratropium treatment of acute airways disease.
Peterson GM; Boyles PJ; Bleasel MD; Vial JH
Ann Pharmacother; 2003 Mar; 37(3):339-44. PubMed ID: 12639159
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations.
Woods JA; Usery JB; Self TH; Finch CK
South Med J; 2011 Nov; 104(11):742-5. PubMed ID: 22024782
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation.
Goggin N; Macarthur C; Parkin PC
Arch Pediatr Adolesc Med; 2001 Dec; 155(12):1329-34. PubMed ID: 11732951
[TBL] [Abstract][Full Text] [Related]
4. Magnesium sulfate versus ipratropium bromide in chronic obstructive pulmonary disease exacerbation: a randomized trial.
Nouira S; Bouida W; Grissa MH; Beltaief K; Trimech MN; Boubaker H; Marghli S; Letaief M; Boukef R
Am J Ther; 2014; 21(3):152-8. PubMed ID: 22407196
[TBL] [Abstract][Full Text] [Related]
5. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
Kässner F; Hodder R; Bateman ED
Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
[TBL] [Abstract][Full Text] [Related]
6. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
Craven D; Kercsmar CM; Myers TR; O'riordan MA; Golonka G; Moore S
J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
[TBL] [Abstract][Full Text] [Related]
7. Effect of nebulized ipratropium on the hospitalization rates of children with asthma.
Qureshi F; Pestian J; Davis P; Zaritsky A
N Engl J Med; 1998 Oct; 339(15):1030-5. PubMed ID: 9761804
[TBL] [Abstract][Full Text] [Related]
8. The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: a systematic review.
Aaron SD
J Asthma; 2001 Oct; 38(7):521-30. PubMed ID: 11714074
[TBL] [Abstract][Full Text] [Related]
9. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
10. Principal findings of systematic reviews of acute asthma treatment in childhood.
Castro-Rodriguez JA; J Rodrigo G; E Rodríguez-Martínez C
J Asthma; 2015; 52(10):1038-45. PubMed ID: 26303207
[TBL] [Abstract][Full Text] [Related]
11. The effect of indacaterol during an acute exacerbation of COPD.
Segreti A; Fiori E; Calzetta L; Sabatini M; Segreti V; Rogliani P; Cazzola M
Pulm Pharmacol Ther; 2013 Dec; 26(6):630-4. PubMed ID: 23578980
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC;
Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen.
Shortall SP; Blum J; Oldenburg FA; Rodgerson L; Branscombe JM; Harrow EM
Respir Care; 2002 Feb; 47(2):154-8. PubMed ID: 11812271
[TBL] [Abstract][Full Text] [Related]
15. Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma.
Hossain AS; Barua UK; Roy GC; Sutradhar SR; Rahman I; Rahman G
Mymensingh Med J; 2013 Apr; 22(2):345-52. PubMed ID: 23715360
[TBL] [Abstract][Full Text] [Related]
16. Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma.
Memon BN; Parkash A; Ahmed Khan KM; Gowa MA; Bai C
J Pak Med Assoc; 2016 Mar; 66(3):243-6. PubMed ID: 26968269
[TBL] [Abstract][Full Text] [Related]
17. Metered-dose inhaler ipratropium bromide for children with acute asthma exacerbation: A prospective, non-randomized, observational study.
Nomura O; Ihara T; Morikawa Y; Sakakibara H; Hagiwara Y; Inoue N; Akasawa A
Pediatr Int; 2020 Mar; 62(3):319-323. PubMed ID: 31930755
[TBL] [Abstract][Full Text] [Related]
18. Addition of ipratropium to nebulized albuterol in children with acute asthma presenting to a pediatric office.
Kumaratne M; Gunawardane G
Clin Pediatr (Phila); 2003 Mar; 42(2):127-32. PubMed ID: 12659385
[TBL] [Abstract][Full Text] [Related]
19. Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?
Akkoca Yildiz O; Onen ZP; Demir G; Eriş Gülbay B; Saryal S; Karabiyikoğlu G
Tuberk Toraks; 2006; 54(2):105-13. PubMed ID: 16924565
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic agents in asthma and COPD.
Gross NJ
Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
